Scienture Holdings Enters Material Agreement, Files 8-K
Ticker: SCNX · Form: 8-K · Filed: Aug 15, 2025 · CIK: 1382574
| Field | Detail |
|---|---|
| Company | Scienture Holdings, Inc. (SCNX) |
| Form Type | 8-K |
| Filed Date | Aug 15, 2025 |
| Risk Level | medium |
| Pages | 5 |
| Reading Time | 7 min |
| Key Dollar Amounts | $0.00001, $1.20, $3.87 m, $50,000, $3,000,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, equity-sale, corporate-update
TL;DR
Scienture Holdings (formerly TRxADE HEALTH) filed an 8-K on Aug 13, 2025, detailing a material agreement and equity sales.
AI Summary
Scienture Holdings, Inc. (formerly TRxADE HEALTH, INC.) entered into a material definitive agreement on August 13, 2025. The company also reported on unregistered sales of equity securities and provided a Regulation FD disclosure. The filing includes financial statements and exhibits.
Why It Matters
This 8-K filing indicates significant corporate activity, including a new material agreement and equity transactions, which could impact the company's future operations and stock performance.
Risk Assessment
Risk Level: medium — The filing involves material definitive agreements and unregistered equity sales, which can introduce financial and operational risks.
Key Players & Entities
- Scienture Holdings, Inc. (company) — Registrant
- TRxADE HEALTH, INC. (company) — Former company name
- August 13, 2025 (date) — Date of earliest event reported
FAQ
What is the nature of the material definitive agreement entered into by Scienture Holdings, Inc.?
The filing indicates a material definitive agreement was entered into on August 13, 2025, but the specific details of this agreement are not provided in the provided text.
What was Scienture Holdings, Inc. previously known as?
Scienture Holdings, Inc. was formerly known as TRxADE HEALTH, INC., with previous name changes including TRXADE GROUP, INC. and XCELLINK INTERNATIONAL INC.
What is the primary business of Scienture Holdings, Inc. according to its SIC code?
Scienture Holdings, Inc. is classified under Pharmaceutical Preparations (SIC code 2834).
When was the 8-K filing submitted?
The 8-K filing was submitted on August 15, 2025.
What are the key items reported in this 8-K filing?
The key items reported are Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Regulation FD Disclosure, and Financial Statements and Exhibits.
Filing Stats: 1,649 words · 7 min read · ~5 pages · Grade level 12.6 · Accepted 2025-08-15 17:10:42
Key Financial Figures
- $0.00001 — h registered: Common stock, par value $0.00001 per share SCNX The Nasdaq Stock Mar
- $1.20 — $0.00001 per share at a per share price $1.20 (the " Offering "). The Offering closed
- $3.87 m — any from the Offering was approximately $3.87 million, before deducting the placement a
- $50,000 — for certain expenses in an amount up to $50,000. The representations, warranties and
- $3,000,000 — n Stock in an aggregate amount of up to $3,000,000 pursuant to a form of Common Stock Purc
- $1.76 million — gregate gross proceeds of approximately $1.76 million. As of the date of this Current Repor
Filing Documents
- form8-k.htm (8-K) — 59KB
- ex5-1.htm (EX-5.1) — 13KB
- ex10-1.htm (EX-10.1) — 219KB
- ex10-2.htm (EX-10.2) — 83KB
- ex99-1.htm (EX-99.1) — 14KB
- ex5-1_001.jpg (GRAPHIC) — 3KB
- 0001641172-25-024477.txt ( ) — 636KB
- scnx-20250813.xsd (EX-101.SCH) — 3KB
- scnx-20250813_lab.xml (EX-101.LAB) — 33KB
- scnx-20250813_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. SCIENTURE HOLDINGS, INC. By: /s/ Narasimhan Mani Narasimhan Mani Co-Chief Executive Officer and President August 15, 2024